FDA approval

Eli Lillys booth at ASH 2025 prominently featuring Jaypirca
Pharma

Lilly’s BTK drug Jaypirca enters first-line CLL

Despite a positive first-line readout, Lilly’s Jake Van Naarden has maintained that the primary use of Jaypirca “remains in second line.”
Angus Liu Oct 2, 2026 4:15pm
pivot change turnaround direction walk away

Roche's Gazyva secures FDA nod in 2nd autoimmune indication

Sep 28, 2026 2:29pm
AbbVie

AbbVie notches FDA nod for Ceverel asset Juvmo in Parkinson's

Sep 28, 2026 8:15am
Traffic light go start restart green light

Mirum scores FDA approval for ultra-rare disorder

Sep 25, 2026 4:10pm
Merck Co headquarters

Merck’s Welireg combo nabs FDA nod to expand kidney cancer reach

Sep 25, 2026 11:30am
Asia

Lilly-InnoCare, Elevar, China's 5-year plan—Fierce Pharma Asia

Sep 25, 2026 9:38am